Ser293

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Ser293 - IL2RB (human)

Site Information
SKFFSQLsSEHGGDV SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 9511912

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	leukemia ( 1 ) , T cell leukemia ( 1 )
Relevant cell line - cell type - tissue:	1363-EBV (lymphoblastoid) ( 2 ) , Kit225 (T lymphocyte) ( 1 )

Upstream Regulation
Treatments:	IL-2 ( 1 )

References
1	Osinalde N, et al. (2011) Interleukin-2 signaling pathway analysis by quantitative phosphoproteomics. J Proteomics 75, 177-91 21722762 Curated Info
2	Depontieu FR, et al. (2009) Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy. Proc Natl Acad Sci U S A 106, 12073-8 19581576 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.